Novartis researchers are peering deep inside knees to see if regenerated cartilage is springy like natural cartilage.

Cambridge neighbors, NIBR and Harvard, further disrupt technology. Read how their alliance is accelerating drug discovery.

A conversation with Novartis Chief Digital Officer Bertrand Bodson

Ambitious scientist accelerates research into African genomic diversity and health challenges with internship

Blocking an inflammatory pathway may offer a new way to treat autoimmune disease.

Learn how Novartis is using technology to improve the oncology clinical trial process.

Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.

Our Global Head of Patient Affairs and Policy shares why it’s critical to engage patients throughout the drug development process.